Goldman Sachs’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Goldman Sachs’s Portfolio NVOS Stock Details NVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-19,080	Closed	-$5.36K	–	6400
2024 Q3	$5.36K	Buy	+19,080	New	+$8.91K	﹤0.01%	5727
2023 Q2	–	Sell	-1,415	Closed	-$1.74K	–	6186
2023 Q1	$1.74K	Buy	+1,415	New	+$1.88K	﹤0.01%	5855
2021 Q2	–	Sell	-1,172	Closed	-$41K	–	6619
2021 Q1	$41K	Buy	+1,172	New	+$48.9K	﹤0.01%	5964

Other funds holding NVOS

ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

Goldman Sachs's NVOS Position: Q4 2024 in Review

Goldman Sachs sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q4 2024, closing a stake of 19,080 shares — an estimated $5.36K sold.

Goldman Sachs first reported a position in NVOS in Q1 2021 and held it in 3 quarters. The position peaked at $41K in Q1 2021. 1 fund tracked by Wall St. Rank holds NVOS as of Q4 2024.

Goldman Sachs reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Goldman Sachs sold 19,080 Novo Integrated Sciences, Inc. Common Stock shares in Q4 2024, an estimated $5.36K.
Goldman Sachs first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
Goldman Sachs's Novo Integrated Sciences, Inc. Common Stock position peaked at $41K in Q1 2021.
1 fund tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q4 2024.

Based on Goldman Sachs's 13F filing for Q4 2024, filed 11 Feb 2025.